Screener
CorMedix CRMD Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from CorMedix’s reported figures.
Based on trailing twelve months.
The source filing: CorMedix’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
FAQ
- What is CorMedix's return on equity?
- CorMedix (CRMD) reported return on equity of 65.6% in Q1 2026.
- What is the long-term trend for CorMedix's return on equity?
- Over 4 years (2020 to 2025), CorMedix's return on equity has grown at a 0.6% compound annual growth rate (CAGR), from -64.9% to 66.6%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about CorMedix's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude